Video

How Payers and Providers Can Create an Effective Clinical Cancer Pathway

Bruce A. Feinberg, DO, vice president and chief medical officer of Cardinal Health Specialty Solutions, discusses the key elements of an effective cancer clinical care pathways program.

Bruce A. Feinberg, DO, vice president and chief medical officer of Cardinal Health Specialty Solutions, discusses the key elements of an effective cancer clinical care pathways program.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Tired scared retiree man holding chest with anginal symptoms, pallor and diaphoresis at home. Suffering male with cardiac origin pain, prexcordial pressure, arrhythmia risk, urgent medical attention - Image credit: DimaBerlin | stock.adobe.com
Image credit: Sebastian Kaulitzki | stock.adobe.com
Magnified bone marrow biopsy showing plasma cells with irregular nuclei and multiple myeloma tumor cells infiltrating normal hematopoietic tissue
Health and nutrition: the role of glp-1 in diabetes management with apple and syringe - Image credit: Thanayut | stock.adobe.com
Related Content
Woman doctor nutritionist hands in white shirt with omega 3, vitamin D capsules with green vegan food. The doctor prescribes a prescription for medicines and vitamins at clinic - Image credit: Galina Zhigalova | stock.adobe.com
June 13th 2025

Study Shows High-Dose Vitamin D Boosts Treatment Response in Breast Cancer

Kennedy Ferruggia, Assistant Editor
S2. Ep 56: Insights From a Pharmacy Times Peer Exchange: How to Talk the Talk
June 3rd 2025

S2. Ep 56: Insights From a Pharmacy Times Peer Exchange: How to Talk the Talk

Alexandra Gerlach, Associate Editor
Gloved hand holding blood test sample | Image Credit: © StudioLaMagica - stock.adobe.com
June 13th 2025

Blood Test Outperforms Tissue Biopsy in Detecting HPV+ Head and Neck Cancer

Alexandra Gerlach, Associate Editor
Insights from a Pharmacy Times Peer Exchange: Toxicity Monitoring and Management in Real-World Settings
May 28th 2025

Insights from a Pharmacy Times Peer Exchange: Toxicity Monitoring and Management in Real-World Settings

Alexandra Gerlach, Associate Editor
Molecular model of pembrolizumab | Image Credit: © Dr_Microbe - stock.adobe.com
June 12th 2025

Pembrolizumab Receives FDA Approval for Treatment of Head and Neck Squamous Cell Carcinoma

Alexandra Gerlach, Associate Editor
Chronic kidney disease (CKD) -- Image credit: Kiattisak | stock.adobe.com
June 12th 2025

Finerenone and Empagliflozin Outperform Either Treatment Alone in Patients With CKD

Gillian McGovern, Associate Editor